14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
ADI vs MCHPP: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
ADI Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 7–3 Matrix Metrics)
ADI Overall Winner
6-Pillar Tally: ADI 5 – 1 MCHPP
Matrix Metrics: ADI 7 – 3 MCHPP
As of Nov 16, 2026, Analog Devices, Inc. (ADI) is the stronger overall head-to-head candidate over Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ADI carries a Unified Composite Score of 46.3/100 (HOLD) at $387.87 (24.1x Forward P/E, 35.7% operating margin), whereas MCHPP carries 57.1/100 (HOLD) at $52.64 (N/M Forward P/E, 21.6% operating margin).
Composite vs. Pillar Nuance: While MCHPP currently prints a higher short-term Unified Composite Score (57.1/100 HOLD vs. ADI 46.3/100 HOLD), ADI captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (35.7% vs. 21.6% operating margin) and revenue trajectory (+39.6% vs. +42.2% YoY).
Technical & Structure Timing Caution: ADI trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 45.6); meanwhile MCHPP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ADI vs MCHPP. Trailing 12-month operating profitability (ADI 35.7% vs MCHPP 21.6%) and valuation multiples (ADI 24.1x vs MCHPP N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Investor FAQ ADI vs MCHPP Key Questions & Quantitative Answers
As of Nov 16, 2026, Analog Devices, Inc. (ADI) is the stronger overall head-to-head candidate over Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ADI carries a Unified Composite Score of 46.3/100 (HOLD) at $387.87 (24.1x Forward P/E, 35.7% operating margin), whereas MCHPP carries 57.1/100 (HOLD) at $52.64 (N/M Forward P/E, 21.6% operating margin). Composite vs. Pillar Nuance: While MCHPP currently prints a higher short-term Unified Composite Score (57.1/100 HOLD vs. ADI 46.3/100 HOLD), ADI captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (35.7% vs. 21.6% operating margin) and revenue trajectory (+39.6% vs. +42.2% YoY). Technical & Structure Timing Caution: ADI trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 45.6); meanwhile MCHPP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
ADI leads the Growth & Scale pillar: ADI posts +39.6% YoY revenue growth and +163.5% YoY earnings growth on $13.9B TTM revenue (65.8% gross margin, 35.7% operating margin), compared with MCHPP at +42.2% YoY revenue growth and N/A YoY earnings growth on $5.60B TTM revenue (62.7% gross margin, 21.6% operating margin). On trailing 12-month operating scale, ADI generates $13.9B in USD-normalized revenue versus $5.60B for MCHPP. In operating R&D and SG&A reinvestment, ADI deploys 30.1% of Rev ($4.18B) (2 90-day corporate R&D disclosures) versus 41.1% of Rev ($2.30B) (0 disclosures) for MCHPP.
ADI screens cheaper on headline valuation multiples. ADI trades at 24.1x Forward P/E, 48.6x Trailing P/E, 0.60x PEG, and 14.8x EV/Revenue (35.6% FCF margin), whereas MCHPP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (33.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ADI (12.2% ROE) versus MCHPP (12.6% ROE) capital efficiency.
In options market volatility and institutional positioning, ADI carries 45.8% implied volatility (24th %ile, Compressed (<25th %ile)), a 0.63x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (1.93β · 64% Vol realized risk). By comparison, MCHPP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.16β · 65% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) Research Suite
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.